Innoen D.S.L 1:2:3 Injection

Adult administration

Typically, an adult is administered 500-1,000 mL by slow intravenous infusion. The infusion rate is 300-500 mL per hour (75-120 drops per minute).

Child administration

In children, the administration rate should be 50-100 mL per hour. The dosage and administration rate should be adjusted appropriately according to age, weight, and symptoms.

This drug is an injection solution containing dextrose, which may lead to rapid depletion of Thiamine (Vitamin B1) in the body during administration, increasing the risk of Thiamine deficiency. This drug should not be used in patients with lactic acidosis, hyperhydration, storage dehydration, hypokalemia, and hypernatremia. It should be used with caution in patients with impaired renal function, heart failure, diabetes, reduced urine output due to urinary obstruction, severe liver dysfunction, and hyponatremia. Care should be taken as rapid or excessive administration of this medication may cause cerebral and pulmonary edema or body swelling. Blood glucose, blood electrolyte levels, and fluid balance should be monitored regularly during administration. In special cases such as pregnant or breastfeeding women, children, and the elderly, the components of this medication may leach out slightly, but the associated risk is very low so it need not be avoided. The risks to the fetus and the benefits of treatment should be carefully weighed when administering this medication during pregnancy, and glucose infusion during labor may cause blood glucose abnormalities in the mother and newborn, therefore caution is necessary. Particularly for premature or low-birth-weight infants, careful observation and management are necessary as they are at higher risk of hypoglycemia or hyperglycemia due to difficulties in glucose control. This medication should not be used if it is not completely transparent, and due to the risk of air embolism caused by air in the container, multiple containers should not be connected in succession. This medication should be stored in a sealed container to prevent exposure to air and kept in a cool room away from direct sunlight to maintain its effectiveness over time.

Mild side effects

• Cerebral edema
• pulmonary edema
• peripheral edema

This medication should be stored in a sealed container to prevent exposure to air and kept in a cool room away from direct sunlight. This will help to preserve the medication's effectiveness.

Appearance

A colorless or pale yellow transparent injection solution filled in a colorless, transparent plastic container for intravenous use.

Package unit

500 milliliters